Transparency Market Research

Orthobiologics Market Is Expected to Grow at a CAGR of 5.9% from 2013 to 2019


Albany, NY -- (SBWIRE) -- 09/06/2018 -- The global orthobiologics market is predicted to testify frequent product approval. This could be evident with the launch of NuVasive's AttraX Putty, a next-gen biologics technology in 2016. The product was introduced with the intention of gaining an edge over competitors and expanding the company's product portfolio. In a report by Transparency Market Research (TMR), leading players such as Globus Medical Inc., DePuy Synthes Inc., and Bacterin International Inc. have been profiled while focusing on their key developments and other aspects. The competitive landscape could be marked by the practice of certain business tactics including mergers and acquisitions, distribution improvement, collaborations, and new product development.

As per the findings of TMR, a US$5.5 bn valuation could be achieved by the global orthobiologics market by the end of 2019. On the basis of product, viscosupplementation is expected to score a king's share of the market. In terms of regional growth, Europe and North America could rank higher in the coming years.

Increasing Procedures Carried out for Musculoskeletal Problems Expedite Growth

Orthobiologics is used to accelerate skeletal and tissue healing. In recent years, it has managed to come to the fore due to limitations of allografts and autografts in the treatment of bone injuries and osteoarthritis. One of the primary factors augmenting the demand in the world orthobiologics market could be rising count of treatment procedures performed for musculoskeletal conditions.

Request A Sample:

Massive demand for knee treatment surgeries is forecasted to set the tone for valuable growth in the viscosupplementation market for orthobiologics. Another reason for the rise of this market could be greater efficiency of viscosupplementation products in comparison with non-steroidal anti-inflammatory drugs (NSAIDs). Plunging sales of Medtronic's INFUSE could help the bone morphogenetic proteins (BMPs) market to increase its growth further.

Inadequacy of Reimbursement Policies that Show Transparency Hinders Rise in Demand

Regulatory mandates for treatment and lack of transparent reimbursement policies are envisaged to delay growth in the international orthobiologics market. However, the market could offer profit-making prospects in the coming years, especially in developed regions where the incidence of obesity and arthritis is particularly high. Demand for minimally invasive procedures is observed to grow massive due to the rise of these diseases. These procedures could include growth factor and bone grafting treatments.

Request Brochure of Report:

Furthermore, medical practitioners and patients having an inclination toward the use of stem-cell-based products could fortify the rise of stem cell therapy in the near future. According to a TMR analyst, synthetic bone substitutes and stem-cell-based products are foretold to register telling growth in future years. Rising adoption of sedentary lifestyle, increasing count of sports injuries, and swelling geriatric population could help the orthobiologics market to showcase growth in Asia Pacific. This regional market is projected to grow decently in the near term.

About Transparency Market Research
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,


NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453